European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

8sens.biognostic GmbH, Berlin, Germany (liq)

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

8sens.biognostic GmbH
8sens.biognostic AG

Register

Ut
District Court of Charlottenburg (Berlin) HRB 100204 B
Ut
District Court of Charlottenburg (Berlin) HRB 76852 B

Address

Robert-Rössle-Str. 10, 13125 Berlin, Germany

Corporate purpose

The development, production and distribution of biotechnical processes and products.

Financials

Earnings Revenue Employees

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network

Publications

14 Feb 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022
10 Jan 2024
Annual report
10 Jan 2023
Liq­ui­da­tion · Liquidator: Ilka Renneberg · No longer Managing Director: Matthias Lehmann
30 Dec 2022
Liquidation
1 Oct 2022
Figurative mark
20 May 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021
15 Dec 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
1 Feb 2021 in Fk
Public funding (€163,549): Development of a lateral flow assay (LFA) for simultaneous detection of four bee pathogenic viruses (LAFAS) - Subproject B
8 Oct 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
15 Apr 2020
Original document: “Liste der Gesellschafter“
14 Jun 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
30 Aug 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
2 Nov 2017
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016
18 Oct 2017
Utility patent: Carrier card for simultaneous determination of biochemical markers in liquids with bidirectional data transfer
1 Jan 2017 in Fk
Public funding (€152,422): SME-innovative-18: KSS rapid test - Development of a rapid test for efficient, fast and reliable verification of the bacteriological infestation of cooling lubricants, TP 1
9 May 2016
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015
11 Mar 2016
Word figurative mark
20 Nov 2015
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014
26 Jan 2015
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013
19 Aug 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
1 Sept 2012 as 8Sens Biognostic AG
Wordmark: “IMMUNOSUPERNOVA“
21 Jun 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
5 Mar 2012
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
1 Nov 2010 in Fk
Public funding (€243,212): SME-innovative-6: AMPLI-DYE - Dye Nanocontainer-enhanced immunoassays for future point-of-care applications, subproject 1
16 Jun 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
16 Apr 2010
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
16 Jul 2009
No longer Managing Director (1) · Address
13 Jan 2009
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007
21 Feb 2008
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006
7 May 2007
Patent: Method for the Coupled Enzyme Immunochemical Assay of Analytes by Means of Endogenous Calibrators
11 Oct 2006 as 8Sens.Biognostic AG
Patent: Capsules Encapsulating Solid Particles of Signal-Generating Organic Substances
25 Jan 2006
Managing Director (3) · Change of legal form: 8sens.biognostic AG · Capital: €50,000 · Share­holder agreement · Seat: Berlin, Germany · Legal form: GmbH · Proxy · Corporate Purpose
25 Jan 2006 as 8sens.biognostic AG
Change of legal form: 8sens.biognostic GmbH
1 Sept 2005 in Fk
Public funding (€280,854): Health care by fluorescence multiplexing (FLUOPLEX) - Sub-projects: Presentation of laboratory samples for the use of NC-based multianalyte detection in protein analysis …
28 Apr 2005
Member of the Executive Board (1)
27 Aug 2004 as 8sens.biognostic AG
Reg­is­tra­tion · Member of the Executive Board: Matthias Lehmann, Ilka Renneberg · Capital: €50,000 · Seat: Berlin, Germany · Legal form: AG · Name: 8sens.biognostic AG · Corporate Purpose
16 Jul 2003 as 8Sens Biognostic AG
Patent: Method for the detection of analytes in samples by means of analytical elements

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "8sens.biognostic GmbH, Berlin, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close